ORIGINAL ARTICLE
Ultrastructure of mitochondria and damage to small blood vessels in siblings with the same mutation in the NOTCH 3 and coexisting diseases
More details
Hide details
1
Department of Neuropathology, Institute of Psychiatry and Neurology, Warsaw, Poland
2
Neuroimmunology Laboratory at the II Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
3
II Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
Submission date: 2020-11-18
Acceptance date: 2021-04-21
Publication date: 2021-09-30
Pol J Pathol 2021;72(2):148-159
KEYWORDS
TOPICS
ABSTRACT
We performed ultrastructural studies of mitochondria and evaluated the appearance of small blood vessels of three middle-aged siblings affected by the same mutation in the NOTCH3 gene, causing CADASIL. CADASIL pathognomonic features include granular osmiophilic material (GOM), which we observed. GOMs were located in damaged and thickened basement membranes (BM) of capillaries and arterioles. Our patients were also burdened by type II diabetes (first patient), impaired glucose metabolism (second patient), and hypertension (third patient). The ultrastructure of the capillaries in the first and second patients differed from the third patient. In diabetes/impaired glucose metabolism patients (first and second patients), we observed: pathologies of mitochondria in damaged endothelium and pericytes of capillaries; extremely thickened (BM) with visible remains of vascular cells; well-preserved GOMs anchored in the rebuilt capillary extracellular matrix. We identified degenerated or vestigial small blood vessels of skeletal muscles in the first patient. The capillary damage in the third patient (with hypertension) was milder compared to the diabetes/impaired glucose metabolism patients. We conclude that in patients with a mutation in the NOTCH3 gene, the co-occurrence of diseases such as type II diabetes/impaired glucose metabolism can cause a multiplication the damages to small blood vessels by modifying/masking the pathogenesis of CADASIL.
REFERENCES (38)
1.
Wallace DC. Mitochondrial diseases in man and mouse. Science 1999; 283: 1482-1488.
2.
Khan NA, Govindaraj P, Meena AK, et al. Mitochondrial disorders: challenges in diagnosis and treatment. Indian J Med Res 2015; 141: 13-26.
3.
Tang X, Luo Y-X, Chen H-Z, et al. Mitochondria, endothelial cell function, and vascular diseases. Front Physiol 2014; 5: 1-17.
4.
Perumalsamy LR, Nagala M, Sarin A. Notch-activated signaling cascade interacts with mitochondrial remodeling proteins to regulate cell survival. Proc Natl Acad Sci 2010; 107: 6882-6887.
5.
Masek J, Andersson ER. The developmental biology of genetic Notch disorders. Development 2017; 144: 1743-1763.
6.
Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996; 383: 707-710.
7.
Di Donato I, Bianchi S, De Stefano N, et al. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects. BMC Med 2017; 15: 1-12.
8.
Joutel A, Vahedi K, Corpechot C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 1997a; 350: 1511-1515.
9.
Tikka S, Mykkanen K, Ruchoux MM, et al. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain 2009; 132: 933-939.
10.
He D, Chen D, Li X, et al. The comparisons of phenotype and genotype between CADASIL and CADASILlike patients.
11.
and population-specific evaluation of CADASIL scale in China. J Headache Pain 2016; 17: 1-9.
12.
Panahi M. CADASIL: a pure model for studying cerebral small vessel disease. Doctoral dissertation. Published by Karolinska Institutet, Stockholm 2019; 1-59.
13.
Locatelli M, Padovani A, Pezzini A. Pathophysiological mechanisms and potential therapeutic targets in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Front Pharmacol 2020; 11: 1-13.
14.
Tikka S, Mykkanen K, Junna M, et al. Diagnosing vascular dementia by skin biopsy – uniqueness of CADASIL. In: Khopkar U. Skin Biopsy - Perspectives Vol 9, Publisher In Tech 2011; 183-194.
15.
Lewandowska E, Szpak GM, Wierzba-Bobrowicz T, et al. Capillary vessel wall in CADASIL angiopathy. Folia Neuropathol 2010; 48: 104-115.
16.
Baudrimont M, Dubas F, Joutel A, et al. Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Stroke 1993; 24: 122-125.
17.
Ruchoux MM, Guerouaou D, Vandenhaute B, et al. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol 1995; 89: 500-512.
18.
Buckley AF, Bossen EH. Skeletal muscle microvasculature in the diagnosis of neuromuscular disease. J Neuropathol Exp Neurol 2013; 72: 906-918.
19.
Nowell C, Radtke F. Cutaneous notch signaling in health and disease. Cold Spring Harb Perspect Med 2013; 3: 1-15.
20.
Fouillade Ch, Monet-Lepreˆtre M, Baron-Menguy C, et al. Notch signalling in smooth muscle cells during development and disease. Cardiovasc Res 2012; 95: 138-146.
21.
Opherk C, Peters N, Herzog J, et al. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain 2004; 127: 2533-2539.
22.
Kutcher ME, Herman IM. The pericyte: cellular regulator of microvascular blood flow. Microvasc Res 2009; 77: 235-246.
23.
Sena CM, Pereira AM, Seiça R. Endothelial dysfunction – A major mediator of diabetic vascular disease. Biochim Biophys Acta 2013; 1832: 2216-2231.
24.
Allt G, Lawrenson JG. Pericytes: cell biology and pathology. Cells Tissues Organs 2001; 169: 1–11.
25.
Qiu J, Zheng Y, Hu J. Biomechanical regulation of vascular smooth muscle cell functions: from in vitro to in vivo understanding. J R Soc Interface 2014; 11: 1-13.
26.
Viitanen M, Sundstrom E, Baumann M, et al. Experimental studies of mitochondrial function in CADASIL vascular smooth muscle cells. Exp Cell Res 2013; 319: 134-143.
27.
Formichi P, Radi E, Battisti C. Apoptosis in CADASIL: an in vitro study of lymphocytes and fibroblasts from a cohort of Italian patients. J Cell Physiol 2009; 219: 494-502.
28.
Dromparis P, Michelakis ED. Mitochondria in vascular health and disease. Annu Rev Physiol 2013; 75: 95-126.
29.
Takahashi K, Adachi K, Yoshizaki K, et al. Mutations in NOTCH3 cause the formation and retention of aggregates in the endoplasmic reticulum, leading to impaired cell proliferation. Hum Mol Genet 2010; 19: 79-89.
30.
Dziewulska D, Nycz E, Rajczewska-Oleszkiewicz C, et al. Nuclear abnormalities in vascular myocytes in cerebral autosomal-dominant arteriopathy with cubcortical infarcts and leukoencephalopahty (CADASIL). Neuropathol 2018; 38: 601-608.
31.
LeBleu VS, MacDonald B, Kalluri R. Structure and function of basement membranes. Exp Biol Med 2007; 232: 1121-1129.
32.
Baum O, Bigler M. Pericapillary basement membranę thickening in human skeletal muscle. Am J Physiol Heart Circ Physiol 2016; 311: H654-H666.
33.
Madonna R, Balistreri CR, Geng Y-J, et al. Diabetic microangiopathy: pathogenetic insights and novel therapeutic approaches. Vasc Pharmacol 2017; 90: 1-7.
34.
Viswanathan A, Gray F, Bousser M-G, et al. Cortical neuronal apoptosis in CADASIL. Stroke 2006; 37: 2690-2695.
35.
Gray F, Polivka M, Viswanathan A, et al. Apoptosis in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol 2007; 66: 597-607.
36.
Gilmore AP. Anoikis. Cell Death Differ 2005; 12: 1473-1477.
37.
Guadamillas MC, Cerezo A, Del Pozo MA. Overcoming anoikis – pathways to anchorage independent growth in cancer. J Cell Sci 2011; 124: 3189-3197.
38.
Dziewulska D, Nycz E, Rajczewska-Oleszkiewicz C. Changes in the vascular extracellular matrix as a potential cause of myocytes loss via anoikis in Cerebral Autosomal Dominat Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. J Clin Exp Pathol 2017; 7: 1-5.